ARS

SPRY

Tags: US Healthcare Biotechnology

ARS Pharmaceuticals, Inc. Price (SPRY)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

95,215,322

(138.3002)%

Market Cap of ARS (SPRY)

Market cap:

As of , SPRY has a market cap of . This makes SPRY the 5156th most valuable company in the US by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $7.55-18.51
Market Cap 1.11B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
IPO Date: December, 04, 2020
Country: US
Currency: USD
Headquaters: San Diego, CA
Employees: 23

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: